Mwanzo068270 • KRX
add
Celltrion Inc
Bei iliyotangulia
₩ 191,200.00
Bei za siku
₩ 192,400.00 - ₩ 196,500.00
Bei za mwaka
₩ 138,500.00 - ₩ 241,000.00
Thamani ya kampuni katika soko
42.17T KRW
Wastani wa hisa zilizouzwa
elfu 588.09
Uwiano wa bei na mapato
94.61
Mgao wa faida
0.26%
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (KRW) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 874.74B | 66.94% |
Matumizi ya uendeshaji wa biashara | 295.34B | 216.97% |
Mapato halisi | 78.01B | -47.11% |
Kiwango cha faida halisi | 8.92 | -68.31% |
Mapato kwa kila hisa | 377.00 | -63.54% |
EBITDA | 204.70B | -14.53% |
Asilimia ya kodi ya mapato | 24.71% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (KRW) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 1.03T | 53.19% |
Jumla ya mali | 20.13T | 220.09% |
Jumla ya dhima | 3.13T | 65.33% |
Jumla ya hisa | 16.99T | — |
hisa zilizosalia | 206.33M | — |
Uwiano wa bei na thamani | 2.34 | — |
Faida inayotokana na mali | 0.90% | — |
Faida inayotokana mtaji | 0.94% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (KRW) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 78.01B | -47.11% |
Pesa kutokana na shughuli | 293.61B | 3.31% |
Pesa kutokana na uwekezaji | 103.88B | 212.18% |
Pesa kutokana na ufadhili | -246.57B | -287.43% |
Mabadiliko halisi ya pesa taslimu | 157.08B | 22.54% |
Mtiririko huru wa pesa | 102.18B | -12.49% |
Kuhusu
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
2002
Tovuti
Wafanyakazi
2,391
